Pfizer Expands its Collaboration with Flatiron Health to Integrate the Use of Real-World Evidence in Oncology

 Pfizer Expands its Collaboration with Flatiron Health to Integrate the Use of Real-World Evidence in Oncology

Pfizer Expands its Collaboration with Flatiron Health to Integrate the Use of Real-World Evidence in Oncology

Shots:

  • Pfizer will utilize Flatiron’s de-identified, real-world datasets and analytical expertise to inform development strategies for clinical development projects across multiple tumor types and will jointly explore other ways to drive clinical development innovation with real-world data
  • The collaboration focuses on integrating real-world data insights into clinical development across Pfizer’s oncology portfolio and will identify the future areas of collaboration which will evolve real-world evidence
  • The collaboration includes datasets from multiple tumor types including NSCLC & CRC and will explore the implications of real-world data with the scientific and healthcare communities to utilize it in making a regulatory decision

Click here to­ read full press release/ article | Ref: Pfizer | Image: Stat

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post